BUREAU VERITAS: Number of shares and voting rights as of February 28, 2026 REGULATED INFORMATION Courbevoie, France – March 6, 2026 Information on number of shares and voting rights as provided by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights28/02/2026453,900,202Theoretical number of voting rights: 560,823,062Number of exercisable voting rights: 550,633,982 (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2026, if ...
BUREAU VERITAS : Nombre d'actions et de droits de vote au 28 février 2026 INFORMATION RÈGLEMENTÉE Courbevoie, France – 6 mars 2026 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêtéNombre d’actions en circulation (1)Nombre total de droits de vote28/02/2026453 900 202Nombre de droits de vote théoriques : 560 823 062Nombre de droits de vote exerçables : 550 633 982 (1) y compris les actions nouvelles créées en Euroclear du fait des levées d’options ...
2025 marked a turning point for Cellnex as its Free Cash Flow generation accelerated. Moreover, the company continues to reduce leverage, through growth and divestments, to meet its leverage target of 5.0-6.0x net debt to EBITDA. We continue to believe the notes look attractive.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.